Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-8-5
|
pubmed:abstractText |
Since an efficient control of virus infections may depend on the appropriate lymphokine profile, we studied cytokine responses and CD30 induction, a recently proposed surrogate marker of type 2 cells, in 10 healthy anti-hepatitis C virus (HCV)-seropositive blood donors without viremia (group A) and in 15 patients with hepatitis C (group B). Intracytoplasmic IFN-gamma, IL-2, IL-4, and IL-10 were determined by triple-color flow cytometry in the CD3+ and CD3+/CD30+ lymphocyte subsets after stimulation of PBMC with rHCV core protein and five core-derived peptides corresponding to the four immunodominant Th epitopes C.T1 to C.T4. In group A, more type 1 cytokines were induced by the rHCV core protein and all immunodominant core peptides (p < 0.05), whereas IL-10-producing T cells were found more frequently in group B. Induction of CD30+ T cells was found almost exclusively in group B (p < 0.01). The difference in cytokine responses was due to the CD3+/CD30- T cell subset and not the CD3+/CD30+ subset, which predominantly produced both IL-10 and IFN-gamma, but only small amounts of IL-2 and IL-4. We conclude that immunodominant HCV core peptides induce preferentially type 1 cytokines in healthy anti-HCV-positive blood donors and CD30 expression in patients with chronic hepatitis C. However, in both groups, CD30+ T lymphocytes produce an intermediate Th0-like cytokine profile. Thus, chronicity in HCV infection may reflect a lack of type 1 cytokine production.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD30,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis C Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Core Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/nucleocapsid protein, Hepatitis C...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
159
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1012-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9218624-Adult,
pubmed-meshheading:9218624-Aged,
pubmed-meshheading:9218624-Antigen Presentation,
pubmed-meshheading:9218624-Antigens, CD30,
pubmed-meshheading:9218624-Chronic Disease,
pubmed-meshheading:9218624-Cytokines,
pubmed-meshheading:9218624-Female,
pubmed-meshheading:9218624-Hepacivirus,
pubmed-meshheading:9218624-Hepatitis C,
pubmed-meshheading:9218624-Hepatitis C Antigens,
pubmed-meshheading:9218624-Humans,
pubmed-meshheading:9218624-Male,
pubmed-meshheading:9218624-Middle Aged,
pubmed-meshheading:9218624-T-Lymphocyte Subsets,
pubmed-meshheading:9218624-Viral Core Proteins
|
pubmed:year |
1997
|
pubmed:articleTitle |
CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes.
|
pubmed:affiliation |
Department of General Internal Medicine, University of Bonn, Germany. UMM21E@ibm.rhrz.uni-bonn.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|